Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations
- PMID: 12937771
- DOI: 10.1590/s0074-02762003000400022
Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations
Abstract
In experimental murine infections with Trypanosoma rangeli it has been observed development immune response to Trypanosoma cruzi. The aim of the present work was to analyze the result of antigenic stimuli and the protective effect with T. rangeli in T. cruzi infections. Mice groups immunized with metacyclic trypomastigotes of T. rangeli (Choach -2V strain), derived from haemolymph and salivary gland and reinfected with T. cruzi virulent populations (Tulahuen strain, SA strain and Dm28c clone) from infected in vitro cells, showed decrease severity of disease outcomes, low parasitemia levels and 100% survival of all mice immunized, in comparison with groups infected only with T. cruzi populations, which demonstrated tissue affection, high parasitemia levels and the death of all animals. The above mentioned data contribute to understand the biological behaviour of T. cruzi and T. rangeli and their interaction with vertebrate host.
Similar articles
-
A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection.Rev Soc Bras Med Trop. 2020 Sep 11;53:e20190608. doi: 10.1590/0037-8682-0608-2019. eCollection 2020. Rev Soc Bras Med Trop. 2020. PMID: 32935777 Free PMC article.
-
Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.Am J Trop Med Hyg. 1991 Apr;44(4):413-9. doi: 10.4269/ajtmh.1991.44.413. Am J Trop Med Hyg. 1991. PMID: 1828328
-
[Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].Bol Chil Parasitol. 1998 Jul-Dec;53(3-4):45-51. Bol Chil Parasitol. 1998. PMID: 10413878 Spanish.
-
Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection.Mem Inst Oswaldo Cruz. 2008 Jun;103(4):370-4. doi: 10.1590/s0074-02762008000400010. Mem Inst Oswaldo Cruz. 2008. PMID: 18660992
-
Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease.Microbes Infect. 2009 Nov;11(13):1037-45. doi: 10.1016/j.micinf.2009.07.011. Epub 2009 Aug 4. Microbes Infect. 2009. PMID: 19660570 Review.
Cited by
-
American trypanosomiasis, or Chagas disease, in Panama: a chronological synopsis of ecological and epidemiological research.Parasit Vectors. 2017 Oct 10;10(1):459. doi: 10.1186/s13071-017-2380-5. Parasit Vectors. 2017. PMID: 29017584 Free PMC article. Review.
-
Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.Clin Vaccine Immunol. 2007 Aug;14(8):1045-9. doi: 10.1128/CVI.00127-07. Epub 2007 May 23. Clin Vaccine Immunol. 2007. PMID: 17522327 Free PMC article.
-
Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.Vaccine. 2007 May 10;25(19):3855-8. doi: 10.1016/j.vaccine.2007.01.114. Epub 2007 Mar 8. Vaccine. 2007. PMID: 17349724 Free PMC article.
-
Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease.Int J Mol Sci. 2025 Feb 12;26(4):1544. doi: 10.3390/ijms26041544. Int J Mol Sci. 2025. PMID: 40004010 Free PMC article.
-
A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection.Rev Soc Bras Med Trop. 2020 Sep 11;53:e20190608. doi: 10.1590/0037-8682-0608-2019. eCollection 2020. Rev Soc Bras Med Trop. 2020. PMID: 32935777 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical